Dash Bio
dash.bio
Actively hiring
Robotics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$47.5M
3 rounds on record
Latest round
$30M
Series A · Aug 2026 · 1 mo ago
Backers
2
A-Level Capital, Oak HC/FT
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Aug 2026 | $30M | Freestyle Capital, Swift Ventures | Pulse 2.0 |
| Venture round | Jul 2025 | $11M | — | streetinsider.com |
| Seed | Oct 2024 | $6.5M | — | PRNewswire |
Backed byfrom the funds' portfolios and accelerator catalogs
A-Level Capital 
Oak HC/FT Similar startupsby what they do, their industry and backers
GridCARE is the essential one-stop power solution for AI data centers, delivering energy security and resilience at unprecedented speed.
Experience unparalleled quality with FirstClub's curated selection of premium produce and products.
Partner with August Bioservices for high-quality, scalable sterile injectable manufacturing. Supporting early-phase to commercial…
To find the right drug for the right target…. Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented…
梅卡曼德机器人科技有限公司（Mech-Mind Robotics）是国内知名的AI+3D+智能工业机器人解决方案提供商，专注于3D视觉领域软硬件产品研发、生产及销售的高新技术企业。梅卡曼德机器人由清华海归团队于2016年10月创办，致力于将智能赋予工业机器人。梅卡曼德总部位于北京…
Frinks AI empowers manufacturers to seamlessly integrate advanced AI for quality control and visual inspection in production lines…
News
Dash Bio Raises $30 Million Series A To Expand Automated Bioanalysis Platform
Dash Bio has raised $30 million in Series A financing to expand its automated bioanalysis platform for pharmaceutical and biotechnology companies. Oak HC/FT led the round, with participation from existing investors Freestyle Capital and Swift Ventures. Th
Read more
Report
Dash Bio: $11 Million Closed To Advance Bioanalysis Platform
Dash Bio, a bioanalysis company specializing in rapid and scalable drug development, has announced an additional $11 million in funding, bringing its total to $17.5 million. Led by The Aligned Fund, investors include Freestyle Capital, Cybernetix Ventures
Read more
Report
Dash Bio Secures $11M to Accelerate a New Era in Bioanalysis -- Bringing Total Funding to $17.5M
Dash Bio, a preclinical and clinical bioanalysis company reinventing the speed and scalability of drug development, today announced it has raised an additional $11 million in funding, bringing its total raised to $17.5 million. The new financing was led b
Read more
Report
Dash Bio Secures $11M to Accelerate a New Era in Bioanalysis -- Bringing Total Funding to $17.5M
/PRNewswire/ -- Dash Bio, a preclinical and clinical bioanalysis company reinventing the speed and scalability of drug development, today announced it has...
Read more
Report
Dash Bio Secures $11M To Accelerate A New Era In Bioanalysis -- Bringing Total Funding To $17.5M
Dash Bio Secures $11M To Accelerate A New Era In Bioanalysis -- Bringing Total Funding To $17.5M.Dash Bio
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1